Much like transcatheter aortic valve implantation (TAVI), transcatheter treatment of mitral regurgitation should be carefully introduced into clinical practice, a document from four organizations involved in cardiology or thoracic surgery stated.
 Your new post is loading...
Scoop.it!
Surgery News is the official news publication of the American College of Surgeons. Surgery News provides surgeons with timely and relevant news and commentary about clinical developments and the impact of health care policy on surgical practice. 
Scoop.it!
Surgery is thought to be life-saving for people who have ischemic mitral regurgitation, but it is unknown whether surgical repair or surgical replacement of the mitral valve is the better procedure. Repair is thought to result in fewer preoperative deaths and replacement is thought to have better long-term outcomes with a reduced incidence of recurrent mitral regurgitation. In recent years, many surgeons have grown to favor repair. Currently about two-thirds of patients in the US undergo a repair operation.
Scoop.it!
A coalition of physicians' groups petition the Centers for Medicare & Medicaid to issue a coverage decision for transcatheter mitral valve implantation systems such as Abbott Labs' recently approved MitraClip.
Scoop.it!
Surgery is thought to be life-saving for people who have ischemic mitral regurgitation, but it is unknown whether surgical repair or surgical replacement of the mitral valve is the better procedure.
Scoop.it!
Neovasc Inc. (TSXV: NVC) today announced that the first patent covering the company's innovative Tiara™ transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office. The new patent protects key aspects of the Tiara mitral valve prosthesis. It is the first patent to issue from a portfolio of US and international patent applications Neovasc has filed aimed at establishing an extensive intellectual property estate covering the entire Tiara program, including the prosthesis, delivery system, associated accessories and methods of use. Tiara is in development for the treatment of severe mitral valve disease.
Scoop.it!
When a valve in the heart isn’t working efficiently, surgery may be necessary. There may be an advantage to replacing the valve rather than just repairing it, but not a very big one. A recent study looked at the differences between mitral valve replacement and mitral valve repair in a group of patients who had ischemic mitral valve regurgitation. The results of the study showed that valve replacement was more durable, but other clinical measures were similar between the groups.
Scoop.it!
It offers a less invasive way to treat somebody's leaking heart valve, particularly for a more elderly, frail patient who can't undergo the standard, which is open-heart surgery.
Scoop.it!
“The case for medicine flexibilityClinton HeraldEndocarditis and dental work DEAR DR. ROACH: How effective is premedication for dental work? Because of mitral valve surgery I had 11 years ago, I always take antibiotics before dental procedures.”
Scoop.it!
Post by WIRED4LIFE.
“Q. What are the reasons for needing a (mitral) valve repair, as opposed to a replacement? A. The decision between repairing or replacing the valve... (Q. What are the reasons for needing a (mitral) valve repair, as opposed to a replacement?”
Scoop.it!
“ Mitraclip is an alternative to mitral valve replacement that may offer hope to those who are too ill to undergo open heart surgery.”
Scoop.it!
“ W. Clark Hargrove, III, MD, is a national leader in minimally invasive port-access mitral valve repair. In this video, he discusses the benefits of mitral va...”
Scoop.it!
“Neovasc Inc. has announced that a first patent covering the company’s innovative Tiara™ transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office.”
Scoop.it!
“Neovasc, a medical device company, has obtained the first patent from the US Patent and Trademark Office (USPTO) for its Tiara transcatheter mitral va (Neovasc obtains US patent for Tiara transcatheter mitral valve replacement technology: Neovasc,...”
Scoop.it!
Leading cardiac surgery program and patient advocacy website join forces to raise awareness to heart valve disease. | Virtual Strategy Magazine is an online publication devoted entirely to virtualization technologies.
Scoop.it!
Early surgical repair of severe mitral valve regurgitation from flail leaflets improved long-term outcomes compared with waiting until symptoms or other surgical indications appeared, a registry study showed.
Scoop.it!
A single-centre, observational study, published in Interactive Cardiovascular and Thoracic Surgery, showed that transcatheter aortic valve implantation (TAVI) with a self-expanding valve (CoreValve, Medtronic) was a safe and effective treatment for nine severe aortic stenosis patients who had previously undergone mitral valve surgery.
Scoop.it!
TransCardiac Therapeutics Inc.'s ("TCT" or the "Company") Chief Scientific Officer, Dr. Omar Lattouf, was invited by the organizers of the Transcatheter Cardiovascular Therapeutics conference to present the Company's minimally invasive mitral valve repair device, the TransCardiac MitraFlex.
Scoop.it!
A debate at the 25th annual TCT Conference on the merits of robotic surgery for the treatment of mitral valve disease actually came to more common ground than conflict.
Scoop.it!
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M. Additional Series A investors include BioMedInvest II LP and Edwards LifeSciences (NYSE: EW). Lead investors Wellington Partners and Seventure Partners, added to their investment from the first close, which also included High-Tech Gruenderfonds.
Scoop.it!
TORONTO, Oct. 10, 2013 /PRNewswire/ -- Dynamic US Market For Heart Valve Devices Will See Rapid Expansion Through 2022. Competitors Seeking To Replicate Success of Edwards Lifesciences' SAPIEN Valve, According to Millennium Research Group.
Scoop.it!
In March, an advisory panel voted 5-3 that the benefits of the MitraClip outweigh the risks. But the panel felt Abbott did not prove MitraClip offered a better benefit-risk profile than surgery.
Scoop.it!
Pushing the envelope on conventional surgical procedures in marginal donor hearts (both before and after transplantation) may not only improve the patient’s functional status and reduce the need for retransplantation, but it may ultimately alleviate the chronic shortage of donor hearts.
Scoop.it!
The mitral valve prolapse doesn't create too much trouble typically. Not often, there may be a leakage through which blood may go out in wrong way in floppy valve. This is the most common illness that approximately five to ten percent of total population in the world is going through this.
Scoop.it!
“ The NeoChord DS1000 (A) has the following features: A tip with expandable jaws to grasp the leaflet and 4 fiber-optic channels (B) each of which correspon”
|
Curated by Beeyond
BEEYOND is a consulting company in the field of disruptive innovation, accompanying established companies on out-of-the-core growth strategy, from creation of new concepts to product launch. Reach us at: contact@beeyond.fr.
Other Topics
#dotdot, the community internet
Aidants
Aston-Martin
Augmented & Virtual Reality
Blue Ocean Strategy
Brain Computer Interfaces & connected medical devices
Consumer Digital Health
Covid-19, SARS-Cov-2, vaccines, Remdesivir, Chloroquine...and all that Jazz
Critical Limb-Threatening Ischemia (CLTI)
Daily realities of diabetic patients
Fashion & technology
Healthcare: reloaded...
High level trending in...
In-Vitro Diagnostic
Innovating to what's next...
Instrumental cosmetics
Interventional Cardiology
Intra-Dermal drug delivery: Opportunities and Challenges?
Local delivery for Gene Directed Enzyme Prodrug Therapy
Engineered MSCs with suicide genes delivered intra-arterially to treat various cancers. Local delivery bypasses homing issues that plagued prior GDEPT programs.
Metabolic Activation Therapy
Neurovascular Intervention
Nudges
Peritoneal dialysis
Sclérose en Plaques
Solid tumors: latest on treaments and research pathways
glioblastoma, craniopharyngioma...
Tailored Expertise Sourcing & Market Intelligence in Global Consulting
The future of e-cigarette
The Revolution Of The Car Industry
Track & Trace
Transcatheter Treatment of Mitral Regurgitation
|
